Sections

SEARCH

\protect\hyperlink{site-content}{Skip to
content}\protect\hyperlink{site-index}{Skip to site index}

\href{https://myaccount.nytimes3xbfgragh.onion/auth/login?response_type=cookie\&client_id=vi}{}

\href{https://www.nytimes3xbfgragh.onion/section/todayspaper}{Today's
Paper}

Advertisement

\protect\hyperlink{after-top}{Continue reading the main story}

\hypertarget{katie-thomas}{%
\section{Katie Thomas}\label{katie-thomas}}

\subsection{}

Katie Thomas has been a reporter for The New York Times since 2008. She
currently covers the business of health care, with a focus on the drug
industry. She has spent the last few years reporting on the issue of
high drug prices.

More**

Advertisement

\protect\hyperlink{after-mid1}{Continue reading the main story}

\begin{itemize}
\tightlist
\item
  \protect\hyperlink{stream-panel}{Latest}
\item
  Search
\end{itemize}

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\item
  \href{/2020/08/04/health/trump-plasma.html}{}

  \includegraphics{https://static01.graylady3jvrrxbe.onion/images/2020/07/31/science/31VIRUS-PLASMA1/31VIRUS-PLASMA1-thumbWide.jpg?quality=75\&auto=webp\&disable=upscale}

  \hypertarget{as-trump-praises-plasma-researchers-struggle-to-finish-critical-studies}{%
  \subsection{As Trump Praises Plasma, Researchers Struggle to Finish
  Critical
  Studies}\label{as-trump-praises-plasma-researchers-struggle-to-finish-critical-studies}}

  Thousands of Covid-19 patients have been treated with blood plasma
  outside of rigorous clinical trials --- hampering research that would
  have shown whether the therapy worked.

  By Katie Thomas and Noah Weiland
\item
  \href{/2020/08/04/health/covid-19-vaccine-novavax.html}{}

  \includegraphics{https://static01.graylady3jvrrxbe.onion/images/2020/08/04/science/04VIRUS-NOVAVAX1/04VIRUS-NOVAVAX1-thumbWide.jpg?quality=75\&auto=webp\&disable=upscale}

  \hypertarget{scientists-are-optimistic-about-new-vaccine-studies-from-novavax}{%
  \subsection{Scientists Are Optimistic About New Vaccine Studies From
  Novavax}\label{scientists-are-optimistic-about-new-vaccine-studies-from-novavax}}

  The company has received a \$1.6 billion grant from the government's
  Operation Warp Speed to have 100 million doses ready by early 2021.

  By Carl Zimmer and Katie Thomas
\item
  \href{/2020/08/02/us/politics/coronavirus-vaccine.html}{}

  \includegraphics{https://static01.graylady3jvrrxbe.onion/images/2020/08/02/us/politics/02dc-virus-vaccine-trump/02dc-virus-vaccine-trump-thumbWide.jpg?quality=75\&auto=webp\&disable=upscale}

  \hypertarget{scientists-worry-about-political-influence-over-coronavirus-vaccine-project}{%
  \subsection{Scientists Worry About Political Influence Over
  Coronavirus Vaccine
  Project}\label{scientists-worry-about-political-influence-over-coronavirus-vaccine-project}}

  Operation Warp Speed has moved along at a rapid clip. But some people
  involved in the process fear pressure to deliver an October surprise
  for President Trump.

  By Sharon LaFraniere, Katie Thomas, Noah Weiland, Peter Baker and
  Annie Karni
\item
  \href{/2020/07/31/health/covid-19-vaccine-sanofi-gsk.html}{}

  \includegraphics{https://static01.graylady3jvrrxbe.onion/images/2020/07/31/science/31VIRUS-SANOFI1/31VIRUS-SANOFI1-thumbWide.jpg?quality=75\&auto=webp\&disable=upscale}

  \hypertarget{sanofi-and-glaxosmithkline-snag-biggest-coronavirus-vaccine-deal-yet}{%
  \subsection{Sanofi and GlaxoSmithKline Snag Biggest Coronavirus
  Vaccine Deal
  Yet}\label{sanofi-and-glaxosmithkline-snag-biggest-coronavirus-vaccine-deal-yet}}

  The arrangement brings the Trump administration's investment in
  coronavirus vaccine projects to more than \$8 billion. The head of the
  federal effort is a former GSK executive.

  By Katie Thomas
\item
  \href{/2020/07/24/us/politics/trump-drug-prices-coronavirus.html}{}

  \includegraphics{https://static01.graylady3jvrrxbe.onion/images/2020/08/23/us/politics/23dc-virus-drugprices/merlin_174915654_c7a3e9eb-7663-4f44-8f43-780e9928cf2e-thumbWide.jpg?quality=75\&auto=webp\&disable=upscale}

  \hypertarget{as-he-woos-drugmakers-on-virus-trump-demands-drug-price-controls}{%
  \subsection{As He Woos Drugmakers on Virus, Trump Demands Drug Price
  Controls}\label{as-he-woos-drugmakers-on-virus-trump-demands-drug-price-controls}}

  President Trump is trying to revive a 2016 campaign promise to control
  the rising price of medicines, but new executive orders are coming
  when he needs drugmakers to deliver coronavirus treatments.

  By Margot Sanger-Katz, Noah Weiland and Katie Thomas
\item
  \href{/2020/07/16/health/coronavirus-vaccine-novavax.html}{}

  \includegraphics{https://static01.graylady3jvrrxbe.onion/images/2020/07/15/science/15VIRUS-NOVAVAX1/15VIRUS-NOVAVAX1-thumbWide.jpg?quality=75\&auto=webp\&disable=upscale}

  \hypertarget{how-a-struggling-company-won-16-billion-to-make-a-coronavirus-vaccine}{%
  \subsection{How a Struggling Company Won \$1.6 Billion to Make a
  Coronavirus
  Vaccine}\label{how-a-struggling-company-won-16-billion-to-make-a-coronavirus-vaccine}}

  Novavax just received the Trump administration's largest vaccine
  contract. In the Maryland company's 33-year history, it has never
  brought a vaccine to market.

  By Katie Thomas and Megan Twohey
\item
  \href{/2020/07/09/health/regeneron-monoclonal-antibodies.html}{}

  \includegraphics{https://static01.graylady3jvrrxbe.onion/images/2020/07/08/science/00virus-regeneron01/00virus-regeneron01-thumbWide.jpg?quality=75\&auto=webp\&disable=upscale}

  \hypertarget{these-scientists-raced-to-find-a-covid-19-drug-then-the-virus-found-them}{%
  \subsection{These Scientists Raced to Find a Covid-19 Drug. Then the
  Virus Found
  Them.}\label{these-scientists-raced-to-find-a-covid-19-drug-then-the-virus-found-them}}

  This spring, researchers at Regeneron's Westchester headquarters found
  themselves in one of the country's first coronavirus hot spots.

  By Katie Thomas
\item
  \href{/2020/07/07/health/novavax-coronavirus-vaccine-warp-speed.html}{}

  \includegraphics{https://static01.graylady3jvrrxbe.onion/images/2020/07/06/science/06virus-warpspeed/06virus-warpspeed-thumbWide.jpg?quality=75\&auto=webp\&disable=upscale}

  \hypertarget{us-will-pay-16-billion-to-novavax-for-coronavirus-vaccine}{%
  \subsection{U.S. Will Pay \$1.6 Billion to Novavax for Coronavirus
  Vaccine}\label{us-will-pay-16-billion-to-novavax-for-coronavirus-vaccine}}

  The Maryland-based company, which has never brought a product to
  market before, just made the biggest deal to date with the Trump
  administration's Operation Warp Speed.

  By Katie Thomas
\item
  \href{/2020/06/24/health/drug-kickbacks-regeneron.html}{}

  \includegraphics{https://static01.graylady3jvrrxbe.onion/images/2020/06/24/science/24REGENERON2/24REGENERON2-thumbWide.jpg?quality=75\&auto=webp\&disable=upscale}

  \hypertarget{regeneron-funneled-kickbacks-through-a-patient-charity-federal-lawsuit-claims}{%
  \subsection{Regeneron Funneled Kickbacks Through a Patient Charity,
  Federal Lawsuit
  Claims}\label{regeneron-funneled-kickbacks-through-a-patient-charity-federal-lawsuit-claims}}

  The case is the latest inquiry into pharmaceutical companies'
  donations to patient assistance charities, which have been blamed for
  inflating the cost of drugs.

  By Katie Thomas
\item
  \href{/2020/06/20/health/hydroxychloroquine-coronavirus-trial.html}{}

  \includegraphics{https://static01.graylady3jvrrxbe.onion/images/2020/06/20/science/20virus-drug/merlin_173191026_480392c1-e26f-4edc-918d-ffd2bb29e81b-thumbWide.jpg?quality=75\&auto=webp\&disable=upscale}

  \hypertarget{federal-agency-halts-studies-of-hydroxychloroquine-drug-trump-promoted}{%
  \subsection{Federal Agency Halts Studies of Hydroxychloroquine, Drug
  Trump
  Promoted}\label{federal-agency-halts-studies-of-hydroxychloroquine-drug-trump-promoted}}

  The National Institutes of Health decided to stop one trial because
  the drug was unlikely to benefit patients, and another because not
  enough people enrolled.

  By Katie Thomas
\end{enumerate}

Show More

Advertisement

\protect\hyperlink{after-mid2}{Continue reading the main story}

\hypertarget{follow-elsewhere}{%
\subsection{Follow Elsewhere}\label{follow-elsewhere}}

\begin{itemize}
\tightlist
\item
  \href{https://twitter.com/katie_thomas}{**katie\_thomastwitter page
  for katie\_thomas}
\end{itemize}

\hypertarget{site-index}{%
\subsection{Site Index}\label{site-index}}

\hypertarget{site-information-navigation}{%
\subsection{Site Information
Navigation}\label{site-information-navigation}}

\begin{itemize}
\tightlist
\item
  \href{https://help.nytimes3xbfgragh.onion/hc/en-us/articles/115014792127-Copyright-notice}{Â©~2020~The
  New York Times Company}
\end{itemize}

\begin{itemize}
\tightlist
\item
  \href{https://www.nytco.com/}{NYTCo}
\item
  \href{https://help.nytimes3xbfgragh.onion/hc/en-us/articles/115015385887-Contact-Us}{Contact
  Us}
\item
  \href{https://www.nytco.com/careers/}{Work with us}
\item
  \href{https://nytmediakit.com/}{Advertise}
\item
  \href{http://www.tbrandstudio.com/}{T Brand Studio}
\item
  \href{https://www.nytimes3xbfgragh.onion/privacy/cookie-policy\#how-do-i-manage-trackers}{Your
  Ad Choices}
\item
  \href{https://www.nytimes3xbfgragh.onion/privacy}{Privacy}
\item
  \href{https://help.nytimes3xbfgragh.onion/hc/en-us/articles/115014893428-Terms-of-service}{Terms
  of Service}
\item
  \href{https://help.nytimes3xbfgragh.onion/hc/en-us/articles/115014893968-Terms-of-sale}{Terms
  of Sale}
\item
  \href{https://spiderbites.nytimes3xbfgragh.onion}{Site Map}
\item
  \href{https://help.nytimes3xbfgragh.onion/hc/en-us}{Help}
\item
  \href{https://www.nytimes3xbfgragh.onion/subscription?campaignId=37WXW}{Subscriptions}
\end{itemize}
